The DOI matches its Crossref record; 314 of the 314 references it cites were found in a registry or an index.
Antibiotics and Bacterial Resistance in the 21st Century
Open accessAbstract
Dangerous, antibiotic resistant bacteria have been observed with increasing frequency over the past several decades. In this review the factors that have been linked to this phenomenon are addressed. Profiles of bacterial species that are deemed to be particularly concerning at the present time are illustrated. Factors including economic impact, intrinsic and acquired drug resistance, morbidity and mortality rates, and means of infection are taken into account. Synchronously with the waxing of bacterial resistance there has been waning antibiotic development. The approaches that scientists are employing in the pursuit of new antibacterial agents are briefly described. The standings of established antibiotic classes as well as potentially emerging classes are assessed with an emphasis on molecules that have been clinically approved or are in advanced stages of development. Historical perspectives, mechanisms of action and resistance, spectrum of activity, and preeminent members of each class are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167
Food-Related Illness and Death in the United States
Mead, P. S., Slutsker, L., Dietz, V., McCaig, L. F., Bresee, J. S., Shapiro, C., Griffin, P. M., & Tauxe, R. V. (1999) · Emerging Infectious Diseases · doi:10.3201/eid0505.990502 · Cited by 7,235
Origins and evolution of antibiotic resistance
Davies, J., & Davies, D. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00016-10 · Cited by 5,784
Antibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Kaper, J. B., Nataro, J. P., & Mobley, H. L. T. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro818 · Cited by 5,583
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
Nikaido, H. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.4.593-656.2003 · Cited by 4,316
J Antimicrob Chemother 1994; 33: 350–351
O'SHAUGHNESSY, E. M., & DAS, S. S. (1994) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/33.2.350 · Cited by 3,746
Klevens, R. M. (2007) · JAMA · doi:10.1001/jama.298.15.1763 · Cited by 3,726 · cited 2×
“Quinolones Balafloxacin, gemifloxacin, pazufloxacin, prulifloxacin Avarofloxacin (65), delafloxacin (63), finafloxacin (66), JNJ-Q2, levonadifloxacin, nemonoxacin (64)”
BackgroundOutpatient antibiotic use in Europe and association with resistance: a cross-national database study
Goossens, H., Ferech, M., Vander Stichele, R., & Elseviers, M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17907-0 · Cited by 3,359
Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2)
Bentley, S. D., Chater, K. F., Cerdeño-Tárraga, A.-M., Challis, G. L., Thomson, N. R., James, K. D., Harris, D. E., Quail, M. A., Kieser, H., Harper, D., et al. (2002) · Nature · doi:10.1038/417141a · Cited by 3,233
Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
Antibiotic resistance is ancient
D’Costa, V. M., King, C. E., Kalan, L., Morar, M., Sung, W. W. L., Schwarz, C., Froese, D., Zazula, G., Calmels, F., Debruyne, R., et al. (2011) · Nature · doi:10.1038/nature10388 · Cited by 2,720
Podschun, R., & Ullmann, U. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.4.589 · Cited by 2,688
Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks
Kluytmans, J., van Belkum, A., & Verbrugh, H. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.3.505 · Cited by 2,595
Yong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K., & Walsh, T. R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00774-09 · Cited by 2,519
Allegranzi, B., Nejad, S. B., Combescure, C., Graafmans, W., Attar, H., Donaldson, L., & Pittet, D. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61458-4 · Cited by 2,514
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
How long do nosocomial pathogens persist on inanimate surfaces? A systematic review
Kramer, A., Schwebke, I., & Kampf, G. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-130 · Cited by 2,504
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,499
Lina, G., Piemont, Y., Godail-Gamot, F., Bes, M., Peter, M.-O., Gauduchon, V., Vandenesch, F., & Etienne, J. (1999) · Clinical Infectious Diseases · doi:10.1086/313461 · Cited by 2,489
Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE
Rice, L. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/533452 · Cited by 2,310
How antibiotics kill bacteria: from targets to networks
Kohanski, M. A., Dwyer, D. J., & Collins, J. J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2333 · Cited by 2,258
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., et al. (2005) · Science · doi:10.1126/science.1106753 · Cited by 2,191
The Uncultured Microbial Majority
Rappé, M. S., & Giovannoni, S. J. (2003) · Annual Review of Microbiology · doi:10.1146/annurev.micro.57.030502.090759 · Cited by 2,017
An Epidemic, Toxin Gene–Variant Strain of Clostridium difficile
McDonald, L. C., Killgore, G. E., Thompson, A., Owens, R. C., Kazakova, S. V., Sambol, S. P., Johnson, S., & Gerding, D. N. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051590 · Cited by 2,006
Antibiotics for Emerging Pathogens
Fischbach, M. A., & Walsh, C. T. (2009) · Science · doi:10.1126/science.1176667 · Cited by 1,777
Vandenesch, F., Naimi, T., Enright, M. C., Lina, G., Nimmo, G. R., Heffernan, H., Liassine, N., Bes, M., Greenland, T., Reverdy, M.-E., et al. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0908.030089 · Cited by 1,727
Spellberg, B., Guidos, R., Gilbert, D., Bradley, J., Boucher, H. W., Scheld, W. M., Bartlett, J. G., Edwards, J., & the Infectious Diseases Society of America (2008) · Clinical Infectious Diseases · doi:10.1086/524891 · Cited by 1,642
Sampling the Antibiotic Resistome
D'Costa, V. M., McGrann, K. M., Hughes, D. W., & Wright, G. D. (2006) · Science · doi:10.1126/science.1120800 · Cited by 1,594
Sievert, D. M., Ricks, P., Edwards, J. R., Schneider, A., Patel, J., Srinivasan, A., Kallen, A., Limbago, B., Fridkin, S., & National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities (2013) · Infection Control & Hospital Epidemiology · doi:10.1086/668770 · Cited by 1,582
Gillet, Y., Issartel, B., Vanhems, P., Fournet, J.-C., Lina, G., Bes, M., Vandenesch, F., Piémont, Y., Brousse, N., Floret, D., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07877-7 · Cited by 1,514
High Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung Infection
Oliver, A., Cantón, R., Campo, P., Baquero, F., & Blázquez, J. (2000) · Science · doi:10.1126/science.288.5469.1251 · Cited by 1,465
Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?
Livermore, D. M. (2002) · Clinical Infectious Diseases · doi:10.1086/338782 · Cited by 1,453
Platforms for antibiotic discovery
Lewis, K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3975 · Cited by 1,445
Metallo-β-Lactamases: the Quiet before the Storm?
Walsh, T. R., Toleman, M. A., Poirel, L., & Nordmann, P. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.2.306-325.2005 · Cited by 1,431
Clinical relevance of the ESKAPE pathogens
Pendleton, J. N., Gorman, S. P., & Gilmore, B. F. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.13.12 · Cited by 1,423
Challenges of Antibacterial Discovery
Silver, L. L. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00030-10 · Cited by 1,376
Essential Bacillus subtilis genes
Kobayashi, K., Ehrlich, S. D., Albertini, A., Amati, G., Andersen, K. K., Arnaud, M., Asai, K., Ashikaga, S., Aymerich, S., Bessieres, P., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730515100 · Cited by 1,328
Humans as the World's Greatest Evolutionary Force
Palumbi, S. R. (2001) · Science · doi:10.1126/science.293.5536.1786 · Cited by 1,290
Ikeda, H., Ishikawa, J., Hanamoto, A., Shinose, M., Kikuchi, H., Shiba, T., Sakaki, Y., Hattori, M., & Ōmura, S. (2003) · Nature Biotechnology · doi:10.1038/nbt820 · Cited by 1,241
The ecology, epidemiology and virulence of Enterococcus
Fisher, K., & Phillips, C. (2009) · Microbiology · doi:10.1099/mic.0.026385-0 · Cited by 1,227
Seppälä, H., Klaukka, T., Vuopio-Varkila, J., Muotiala, A., Helenius, H., Lager, K., & Huovinen, P. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708143370701 · Cited by 1,206
Vancomycin-Resistant Enterococci
Cetinkaya, Y., Falk, P., & Mayhall, C. G. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.4.686 · Cited by 1,163
Epidemic Profile of Shiga-Toxin–Producing Escherichia coli O104:H4 Outbreak in Germany
Frank, C., Werber, D., Cramer, J. P., Askar, M., Faber, M., an der Heiden, M., Bernard, H., Fruth, A., Prager, R., Spode, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1106483 · Cited by 1,139
Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications
Chambers, H. F. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.4.781 · Cited by 1,127
Aminoglycosides: Activity and Resistance
Mingeot-Leclercq, M.-P., Glupczynski, Y., & Tulkens, P. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.727 · Cited by 1,113
Talbot, G. H., Bradley, J., Edwards, J. E., Gilbert, D., Scheld, M., & Bartlett, J. G. (2006) · Clinical Infectious Diseases · doi:10.1086/499819 · Cited by 1,104
Quinolone resistance from a transferable plasmid
Martínez-Martínez, L., Pascual, A., & Jacoby, G. A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07322-4 · Cited by 1,100
Infection with Vancomycin-Resistant Staphylococcus aureus Containing the vanA Resistance Gene
Chang, S., Sievert, D. M., Hageman, J. C., Boulton, M. L., Tenover, F. C., Downes, F. P., Shah, S., Rudrik, J. T., Pupp, G. R., Brown, W. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025025 · Cited by 1,095
Linezolid resistance in a clinical isolate of Staphylococcus aureus
Tsiodras, S., Gold, H. S., Sakoulas, G., Eliopoulos, G. M., Wennersten, C., Venkataraman, L., Moellering, R. C., & Ferraro, M. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05410-1 · Cited by 1,033
Antibiotic-Resistant Bugs in the 21st Century — A Clinical Super-Challenge
Arias, C. A., & Murray, B. E. (2009) · New England Journal of Medicine · doi:10.1056/nejmp0804651 · Cited by 1,027
Update on acquired tetracycline resistance genes
Roberts, M. C. (2005) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2005.02.034 · Cited by 1,010
Pepin, J., Saheb, N., Coulombe, M.-A., Alary, M.-E., Corriveau, M.-P., Authier, S., Leblanc, M., Rivard, G., Bettez, M., Primeau, V., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/496986 · Cited by 995
Global Transposon Mutagenesis and a Minimal Mycoplasma Genome
Hutchison, C. A., Peterson, S. N., Gill, S. R., Cline, R. T., White, O., Fraser, C. M., Smith, H. O., & Craig Venter, J. (1999) · Science · doi:10.1126/science.286.5447.2165 · Cited by 932
Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat
Strahilevitz, J., Jacoby, G. A., Hooper, D. C., & Robicsek, A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00016-09 · Cited by 928
How many antibiotics are produced by the genus Streptomyces ?
Watve, M., Tickoo, R., Jog, M., & Bhole, B. (2001) · Archives of Microbiology · doi:10.1007/s002030100345 · Cited by 923
Platensimycin is a selective FabF inhibitor with potent antibiotic properties
Wang, J., Soisson, S. M., Young, K., Shoop, W., Kodali, S., Galgoci, A., Painter, R., Parthasarathy, G., Tang, Y. S., Cummings, R., et al. (2006) · Nature · doi:10.1038/nature04784 · Cited by 812
Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines
Agwuh, K. N. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl224 · Cited by 806
Efflux-Mediated Drug Resistance in Bacteria
Li, X.-Z., & Nikaido, H. (2004) · Drugs · doi:10.2165/00003495-200464020-00004 · Cited by 798
Munoz-Price, L. S., & Weinstein, R. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmra070741 · Cited by 772
Stermitz, F. R., Lorenz, P., Tawara, J. N., Zenewicz, L. A., & Lewis, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.030540597 · Cited by 761
Prevalence in the United States of aac(6 ′ ) - Ib - cr Encoding a Ciprofloxacin-Modifying Enzyme
Park, C. H., Robicsek, A., Jacoby, G. A., Sahm, D., & Hooper, D. C. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00915-06 · Cited by 757
Liu, G. Y., Essex, A., Buchanan, J. T., Datta, V., Hoffman, H. M., Bastian, J. F., Fierer, J., & Nizet, V. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050846 · Cited by 752
Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas aeruginosa
Bonomo, R. A., & Szabo, D. (2006) · Clinical Infectious Diseases · doi:10.1086/504477 · Cited by 741
Long, K. S., Poehlsgaard, J., Kehrenberg, C., Schwarz, S., & Vester, B. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00131-06 · Cited by 708
Boucher, H. W., Talbot, G. H., Benjamin, D. K., Bradley, J., Guidos, R. J., Jones, R. N., Murray, B. E., Bonomo, R. A., Gilbert, D., & for the Infectious Diseases Society of America (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit152 · Cited by 700
Physicochemical Properties of Antibacterial Compounds: Implications for Drug Discovery
O’Shea, R., & Moser, H. E. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm700967e · Cited by 689
Antimicrobial resistance of Staphylococcus aureus: genetic basis
Lyon, B. R., & Skurray, R. A. (1987) · Microbiological Reviews · doi:10.1128/mmbr.51.1.88-134.1987 · Cited by 686
Emerging carbapenemases in Gram-negative aerobes
Nordmann, P., & Poirel, L. (2002) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2002.00401.x · Cited by 684
Pathogenic fungus harbours endosymbiotic bacteria for toxin production
Partida-Martinez, L. P., & Hertweck, C. (2005) · Nature · doi:10.1038/nature03997 · Cited by 677
Glycopeptide and Lipoglycopeptide Antibiotics
Kahne, D., Leimkuhler, C., Lu, W., & Walsh, C. (2005) · Chemical Reviews · doi:10.1021/cr030103a · Cited by 662
Antibiotics: Actions, Origins, Resistance
Walsh, C. (2003) · Wiley eBooks · doi:10.1128/9781555817886 · Cited by 633
An Antifungal Agent Inhibits an Aminoacyl-tRNA Synthetase by Trapping tRNA in the Editing Site
Rock, F. L., Mao, W., Yaremchuk, A., Tukalo, M., Crépin, T., Zhou, H., Zhang, Y.-K., Hernandez, V., Akama, T., Baker, S. J., et al. (2007) · Science · doi:10.1126/science.1142189 · Cited by 631
van den Bogaard, A. E. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.6.763 · Cited by 622
Has the era of untreatable infections arrived?
Livermore, D. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp255 · Cited by 620
O'Brien, A. D., Newland, J. W., Miller, S. F., Holmes, R. K., Smith, H. W., & Formal, S. B. (1984) · Science · doi:10.1126/science.6387911 · Cited by 617
New antibiotics from bacterial natural products
Clardy, J., Fischbach, M. A., & Walsh, C. T. (2006) · Nature Biotechnology · doi:10.1038/nbt1266 · Cited by 615
Challis, G. L., & Hopwood, D. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1934677100 · Cited by 597
Metabolites from symbiotic bacteria
Piel, J. (2009) · Nat. Prod. Rep. · doi:10.1039/b703499g · Cited by 577
Status of the Microbial Census
Schloss, P. D., & Handelsman, J. (2004) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.68.4.686-691.2004 · Cited by 573
Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria
Li, J., Nation, R. L., Milne, R. W., Turnidge, J. D., & Coulthard, K. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.10.001 · Cited by 571
Resistance to Antimicrobial Drugs—A Worldwide Calamity
Kunin, C. M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-7-199304010-00011 · Cited by 558
Gomez‐Escribano, J. P., & Bibb, M. J. (2011) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2010.00219.x · Cited by 534
Almeida Da Silva, P. E., & Palomino, J. C. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr173 · Cited by 532
Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy
Ejim, L., Farha, M. A., Falconer, S. B., Wildenhain, J., Coombes, B. K., Tyers, M., Brown, E. D., & Wright, G. D. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.559 · Cited by 525
Antibiotics in animal feed and their role in resistance development
Wegener, H. C. (2003) · Current Opinion in Microbiology · doi:10.1016/j.mib.2003.09.009 · Cited by 517
Clauditz, A., Resch, A., Wieland, K.-P., Peschel, A., & Götz, F. (2006) · Infection and Immunity · doi:10.1128/iai.00204-06 · Cited by 509
Dysregulation of bacterial proteolytic machinery by a new class of antibiotics
Brötz-Oesterhelt, H., Beyer, D., Kroll, H.-P., Endermann, R., Ladel, C., Schroeder, W., Hinzen, B., Raddatz, S., Paulsen, H., Henninger, K., et al. (2005) · Nature Medicine · doi:10.1038/nm1306 · Cited by 505
Why is big Pharma getting out of antibacterial drug discovery?
Projan, S. J. (2003) · Current Opinion in Microbiology · doi:10.1016/j.mib.2003.08.003 · Cited by 503
Genome-minimized Streptomyces host for the heterologous expression of secondary metabolism
Komatsu, M., Uchiyama, T., Ōmura, S., Cane, D. E., & Ikeda, H. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914833107 · Cited by 500
Resistance to Trimethoprim-Sulfamethoxazole
Eliopoulos, G. M., & Huovinen, P. (2001) · Clinical Infectious Diseases · doi:10.1086/320532 · Cited by 500
Schaack, S., Gilbert, C., & Feschotte, C. (2010) · Trends in Ecology & Evolution · doi:10.1016/j.tree.2010.06.001 · Cited by 490
Mechanisms of antibiotic resistance in Pseudomonas aeruginosa.
Lambert, P. A. (2002) · Europe PMC (PubMed Central) · Cited by 489
A genome‐wide strategy for the identification of essential genes in Staphylococcus aureus
Forsyth, R. A., Haselbeck, R. J., Ohlsen, K. L., Yamamoto, R. T., Xu, H., Trawick, J. D., Wall, D., Wang, L., Brown‐Driver, V., Froelich, J. M., et al. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02832.x · Cited by 487
The 10 × ‘20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020
(2010) · Clinical Infectious Diseases · doi:10.1086/652237 · Cited by 484
Bacterial Protection of Beetle-Fungus Mutualism
Scott, J. J., Oh, D.-C., Yuceer, M. C., Klepzig, K. D., Clardy, J., & Currie, C. R. (2008) · Science · doi:10.1126/science.1160423 · Cited by 478
Clabots, C. R., Johnson, S., Olson, M. M., Peterson, L. R., & Gerding, D. N. (1992) · Journal of Infectious Diseases · doi:10.1093/infdis/166.3.561 · Cited by 476
Prospects for plant-derived antibacterials
Lewis, K., & Ausubel, F. M. (2006) · Nature Biotechnology · doi:10.1038/nbt1206-1504 · Cited by 474
Tenson, T., Lovmar, M., & Ehrenberg, M. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00662-4 · Cited by 461
Quinolones: a comprehensive review.
Oliphant, C. M., & Green, G. M. (2002) · PubMed · Cited by 454
An Inhibitor of FtsZ with Potent and Selective Anti-Staphylococcal Activity
Haydon, D. J., Stokes, N. R., Ure, R., Galbraith, G., Bennett, J. M., Brown, D. R., Baker, P. J., Barynin, V. V., Rice, D. W., Sedelnikova, S. E., et al. (2008) · Science · doi:10.1126/science.1159961 · Cited by 452
Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii
Vila, J., Martí, S., & Sánchez-Céspedes, J. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl509 · Cited by 436
Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe
Souli, M., Galani, I., & Giamarellou, H. (2008) · Eurosurveillance · doi:10.2807/ese.13.47.19045-en · Cited by 436
Tomasz, A. (1979) · Annual Review of Microbiology · doi:10.1146/annurev.mi.33.100179.000553 · Cited by 433
Antibiotics in the clinical pipeline in 2013
Butler, M. S., Blaskovich, M. A., & Cooper, M. A. (2013) · The Journal of Antibiotics · doi:10.1038/ja.2013.86 · Cited by 433
Birmingham, M. C., Rayner, C. R., Meagher, A. K., Flavin, S. M., Batts, D. H., & Schentag, J. J. (2003) · Clinical Infectious Diseases · doi:10.1086/345744 · Cited by 428
Opacity genes in Neisseria gonorrhoeae: Control of phase and antigenic variation
Stern, A., Brown, M., Nickel, P., & Meyer, T. F. (1986) · Cell · doi:10.1016/0092-8674(86)90366-1 · Cited by 425
Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae
Nordmann, P., & Poirel, L. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki245 · Cited by 425
Emr, an Escherichia coli locus for multidrug resistance.
Lomovskaya, O., & Lewis, K. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.8938 · Cited by 424
Petersen, P. J., Jacobus, N. V., Weiss, W. J., Sum, P. E., & Testa, R. T. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.738 · Cited by 415
Ji, Y., Zhang, B., Van, S. F., Horn, Warren, P., Woodnutt, G., Burnham, M. K. R., & Rosenberg, M. (2001) · Science · doi:10.1126/science.1063566 · Cited by 414
Evolution of Drug Resistance in Mycobacterium tuberculosis : Clinical and Molecular Perspective
Gillespie, S. H. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.267-274.2002 · Cited by 412
Nathan, C. (2004) · Nature · doi:10.1038/431899a · Cited by 410
Mechanisms of Action and Resistance of Older and Newer Fluoroquinolones
Hooper, D. C. (2000) · Clinical Infectious Diseases · doi:10.1086/314056 · Cited by 409
Favorable Impact of a Multidisciplinary Antibiotic Management Program Conducted During 7 Years
Carling, P., Fung, T., Killion, A., Terrin, N., & Barza, M. (2003) · Infection Control & Hospital Epidemiology · doi:10.1086/502278 · Cited by 405
Barth, H., Aktories, K., Popoff, M. R., & Stiles, B. G. (2004) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.68.3.373-402.2004 · Cited by 399
Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae
Bush, K. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.09.006 · Cited by 398
Hansen, J. L., Moore, P. B., & Steitz, T. A. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00668-5 · Cited by 393
Roberts, M. C. (2008) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2008.01145.x · Cited by 392
The bacterial outer membrane as a drug barrier
HANCOCK, R. (1997) · Trends in Microbiology · doi:10.1016/s0966-842x(97)81773-8 · Cited by 388
Collignon, P., Powers, J. H., Chiller, T. M., Aidara‐Kane, A., & Aarestrup, F. M. (2009) · Clinical Infectious Diseases · doi:10.1086/599374 · Cited by 385
Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties
Wang, J., Kodali, S., Lee, S. H., Galgoci, A., Painter, R., Dorso, K., Racine, F., Motyl, M., Hernandez, L., Tinney, E., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700746104 · Cited by 381
Diekema, D. J., & Jones, R. N. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06964-1 · Cited by 378
Kinetics of Avibactam Inhibition against Class A, C, and D β-Lactamases
Ehmann, D. E., Jahić, H., Ross, P. L., Gu, R.-F., Hu, J., Durand-Réville, T. F., Lahiri, S., Thresher, J., Livchak, S., Gao, N., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.485979 · Cited by 372
Efflux-Mediated Resistance to Fluoroquinolones in Gram-Negative Bacteria
Poole, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2233-2241.2000 · Cited by 371
Castanheira, M., Deshpande, L. M., Mathai, D., Bell, J. M., Jones, R. N., & Mendes, R. E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01497-10 · Cited by 362
Akerley, B. J., Rubin, E. J., Novick, V. L., Amaya, K., Judson, N., & Mekalanos, J. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012602299 · Cited by 358
Clancy, J., Petitpas, J., Dib‐Hajj, F., Yuan, W., Cronan, M., Kamath, A. V., Bergeron, J., & Retsema, J. A. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.01521.x · Cited by 358
Markowitz, N., Quinn, E. L., & Saravolatz, L. D. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-5-390 · Cited by 343
communication-from-the-commission-to-the-european-parliament-and-the-council
(2016) · Human Rights Documents online · doi:10.1163/2210-7975_hrd-4679-0058 · Cited by 340
Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review
Planche, T., Aghaizu, A., Holliman, R., Riley, P., Poloniecki, J., Breathnach, A., & Krishna, S. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70233-0 · Cited by 334
Interaction of divalent cations and polymyxin B with lipopolysaccharide
Schindler, M., & Osborn, M. J. (1979) · Biochemistry · doi:10.1021/bi00587a024 · Cited by 334
Kehrenberg, C., Schwarz, S., Jacobsen, L., Hansen, L. H., & Vester, B. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04754.x · Cited by 333
The emerging problem of linezolid-resistant Staphylococcus
Gu, B., Kelesidis, T., Tsiodras, S., Hindler, J., & Humphries, R. M. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks354 · Cited by 332
History of the Development of Rifampin
Sensi, P. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.supplement_3.s402 · Cited by 315
Bister, B., Bischoff, D., Ströbele, M., Riedlinger, J., Reicke, A., Wolter, F., Bull, A. T., Zähner, H., Fiedler, H., & Süssmuth, R. D. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200353160 · Cited by 309
Efflux-Mediated Aminoglycoside and Macrolide Resistance in Burkholderia pseudomallei
Moore, R. A., DeShazer, D., Reckseidler, S., Weissman, A., & Woods, D. E. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.3.465 · Cited by 305
Gales, A. C., Jones, R. N., & Sader, H. S. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01351.x · Cited by 302
Choi, C. H., Lee, E. Y., Lee, Y. C., Park, T. I., Kim, H. J., Hyun, S. H., Kim, S. A., Lee, S.-K., & Lee, J. C. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00538.x · Cited by 301
Resistance to polymyxins: Mechanisms, frequency and treatment options
Falagas, M. E., Rafailidis, P. I., & Matthaiou, D. K. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.05.002 · Cited by 298
RIEDLINGER, J., REICKE, A., ZÄHNER, H., KRISMER, B., BULL, A. T., MALDONADO, L. A., WARD, A. C., GOODFELLOW, M., BISTER, B., BISCHOFF, D., et al. (2004) · The Journal of Antibiotics · doi:10.7164/antibiotics.57.271 · Cited by 296
Identification of novel antimicrobials using a live-animal infection model
Moy, T. I., Ball, A. R., Anklesaria, Z., Casadei, G., Lewis, K., & Ausubel, F. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604055103 · Cited by 294
Nordmann, P., Poirel, L., Toleman, M. A., & Walsh, T. R. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq520 · Cited by 294
Davis, B. D., Chen, L. L., & Tai, P. C. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.16.6164 · Cited by 293
Michalopoulos, A. S., Tsiodras, S., Rellos, K., Mentzelopoulos, S., & Falagas, M. E. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01043.x · Cited by 292
Morales, G., Picazo, J. J., Baos, E., Candel, F. J., Arribi, A., Peláez, B., Andrade, R., de la Torre, M., Fereres, J., & Sánchez‐García, M. (2010) · Clinical Infectious Diseases · doi:10.1086/650574 · Cited by 292
Immune evasion by Mycobacterium tuberculosis: living with the enemy
Flynn, J. L., & Chan, J. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(03)00075-x · Cited by 283
Microbial antagonism: a neglected avenue of natural products research
Burgess, J. G., Jordan, E. M., Bregu, M., Mearns-Spragg, A., & Boyd, K. G. (1999) · Journal of Biotechnology · doi:10.1016/s0168-1656(99)00054-1 · Cited by 280
A global assembly line for cyanobactins
Donia, M. S., Ravel, J., & Schmidt, E. W. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.84 · Cited by 279
Noel, G. J., Bush, K., Bagchi, P., Ianus, J., & Strauss, R. S. (2008) · Clinical Infectious Diseases · doi:10.1086/526527 · Cited by 270
Wegener, H. C., Aarestrup, F. M., Jensen, L. B., Hammerum, A. M., & Bager, F. (1999) · Emerging Infectious Diseases · doi:10.3201/eid0503.990303 · Cited by 265
Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis
Tasina, E., Haidich, A.-B., Kokkali, S., & Arvanitidou, M. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70177-3 · Cited by 260
The oxazolidinones: past, present, and future
Shaw, K. J., & Barbachyn, M. R. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06330.x · Cited by 259
Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii
Peleg, A. Y., Adams, J., & Paterson, D. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01198-06 · Cited by 257
Wachino, J., & Arakawa, Y. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.05.001 · Cited by 255
Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA)
Appelbaum, P. C. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.07.011 · Cited by 248
U.S. Outpatient Antibiotic Prescribing, 2010
Hicks, L. A., Taylor, T. H., & Hunkler, R. J. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1212055 · Cited by 247
Empirical antibacterial drug discovery—Foundation in natural products
Singh, S. B., & Barrett, J. F. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.12.016 · Cited by 245
Emergence of Metallo-β-Lactamase NDM-1-Producing Multidrug-Resistant Escherichia coli in Australia
Poirel, L., Lagrutta, E., Taylor, P., Pham, J., & Nordmann, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00878-10 · Cited by 243
Mycobacterial outer membranes: in search of proteins
Niederweis, M., Danilchanka, O., Huff, J., Hoffmann, C., & Engelhardt, H. (2010) · Trends in Microbiology · doi:10.1016/j.tim.2009.12.005 · Cited by 241
Fishman, N. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.04.003 · Cited by 239
Chastre, J., Wunderink, R., Prokocimer, P., Lee, M., Kaniga, K., & Friedland, I. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181691b99 · Cited by 237
Sutcliffe, J. A., O'Brien, W., Fyfe, C., & Grossman, T. H. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01288-13 · Cited by 235
Singh, S. B., Jayasuriya, H., Ondeyka, J. G., Herath, K. B., Zhang, C., Zink, D. L., Tsou, N. N., Ball, R. G., Basilio, A., Genilloud, O., et al. (2006) · Journal of the American Chemical Society · doi:10.1021/ja062232p · Cited by 232
Current use of aminoglycosides: indications, pharmacokinetics and monitoring for toxicity
Avent, M. L., Rogers, B. A., Cheng, A. C., & Paterson, D. L. (2011) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2011.02452.x · Cited by 231
Genome Mining for Novel Natural Product Discovery
Challis, G. L. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm700948z · Cited by 231
Discovering new antimicrobial agents
Moellering, R. C. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.08.018 · Cited by 227
Page, M. G. P., Dantier, C., & Desarbre, E. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01525-09 · Cited by 227
Hawser, S. P., Bouchillon, S. K., Hoban, D. J., Badal, R. E., Hsueh, P.-R., & Paterson, D. L. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00426-09 · Cited by 224
Boguski, M. S., Mandl, K. D., & Sukhatme, V. P. (2009) · Science · doi:10.1126/science.1169920 · Cited by 220
Freiberg, C., Brunner, N. A., Schiffer, G., Lampe, T., Pohlmann, J., Brands, M., Raabe, M., Häbich, D., & Ziegelbauer, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402989200 · Cited by 218
Canu, A., Malbruny, B., Coquemont, M., Davies, T. A., Appelbaum, P. C., & Leclercq, R. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.1.125-131.2002 · Cited by 218
Margalit, D. N., Romberg, L., Mets, R. B., Hebert, A. M., Mitchison, T. J., Kirschner, M. W., & RayChaudhuri, D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404439101 · Cited by 206
O-Acetyltransferases for chloramphenicol and other natural products
Murray, I. A., & Shaw, W. V. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.1.1 · Cited by 205
Discovery of FabH/FabF Inhibitors from Natural Products
Young, K., Jayasuriya, H., Ondeyka, J. G., Herath, K., Zhang, C., Kodali, S., Galgoci, A., Painter, R., Brown-Driver, V., Yamamoto, R., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.519-526.2006 · Cited by 202
Regev-Yochay, G., Trzciński, K., Thompson, C. M., Malley, R., & Lipsitch, M. (2006) · Journal of Bacteriology · doi:10.1128/jb.00317-06 · Cited by 201
Wang, J., Galgoci, A., Kodali, S., Herath, K. B., Jayasuriya, H., Dorso, K., Vicente, F., González, A., Cully, D., Bramhill, D., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307625200 · Cited by 200
Rice, L. B. (2008) · Clinical Infectious Diseases · doi:10.1086/526535 · Cited by 200
Jayasuriya, H., Herath, K. B., Zhang, C., Zink, D. L., Basilio, A., Genilloud, O., Diez, M. T., Vicente, F., Gonzalez, I., Salazar, O., et al. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200701058 · Cited by 195
Antibiotic acyldepsipeptides activate ClpP peptidase to degrade the cell division protein FtsZ
Sass, P., Josten, M., Famulla, K., Schiffer, G., Sahl, H.-G., Hamoen, L., & Brötz-Oesterhelt, H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110385108 · Cited by 194
Louie, T. J., Emery, J., Krulicki, W., Byrne, B., & Mah, M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01443-07 · Cited by 190
From magic bullets back to the Magic Mountain: the rise of extensively drug-resistant tuberculosis
Dorman, S. E., & Chaisson, R. E. (2007) · Nature Medicine · doi:10.1038/nm0307-295 · Cited by 189
Antimicrobial Use in Animal Feed — Time to Stop
Gorbach, S. L. (2001) · New England Journal of Medicine · doi:10.1056/nejm200110183451610 · Cited by 189
Ouderkirk, J. P., Nord, J. A., Turett, G. S., & Kislak, J. W. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2659-2662.2003 · Cited by 188
Naas, T., & Nordmann, P. (1999) · PubMed · Cited by 183
Arcangioli, M. (1999) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(99)00161-5 · Cited by 182
Shaw, K. J., Poppe, S., Schaadt, R., Brown-Driver, V., Finn, J., Pillar, C. M., Shinabarger, D., & Zurenko, G. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00859-08 · Cited by 181
Wachino, J.-I., Shibayama, K., Kurokawa, H., Kimura, K., Yamane, K., Suzuki, S., Shibata, N., Ike, Y., & Arakawa, Y. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00926-07 · Cited by 180
Henrichfreise, B., Wiegand, I., Pfister, W., & Wiedemann, B. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00148-07 · Cited by 179
New target for inhibition of bacterial RNA polymerase: ‘switch region’
Srivastava, A., Talaue, M., Liu, S., Degen, D., Ebright, R. Y., Sineva, E., Chakraborty, A., Druzhinin, S. Y., Chatterjee, S., Mukhopadhyay, J., et al. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.07.030 · Cited by 172
Novel Trisubstituted Benzimidazoles, Targeting Mtb FtsZ, as a New Class of Antitubercular Agents
Kumar, K., Awasthi, D., Lee, S.-Y., Zanardi, I., Ruzsicska, B. P., Knudson, S. E., Tonge, P. J., Slayden, R. A., & Ojima, I. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1012006 · Cited by 172
Antibacterial activity of quinoxalines, quinazolines, and 1,5-naphthyridines
Parhi, A. K., Zhang, Y., Saionz, K. W., Pradhan, P., Kaul, M., Trivedi, K., Pilch, D. S., & LaVoie, E. J. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.06.048 · Cited by 169
Wittmann, H. G., Stöffler, G., Apirion, D., Rosen, L., Tanaka, K., Tamaki, M., Takata, R., Dekio, S., Otaka, E., & Osawa, S. (1973) · Molecular and General Genetics MGG · doi:10.1007/bf00333665 · Cited by 169
Bacteria lacking a multidrug pump: A sensitive tool for drug discovery
Hsieh, P.-C., Siegel, S. A., Rogers, B., Davis, D., & Lewis, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6602 · Cited by 167
Antimicrobial resistance: action to combat the rising microbial challenges
Paphitou, N. I. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.04.007 · Cited by 163
Target- and resistance-based mechanistic studies with TP-434, a novel fluorocycline antibiotic
Grossman, T. H., Starosta, A. L., Fyfe, C., O'Brien, W., Rothstein, D. M., Mikolajka, A., Wilson, D. N., & Sutcliffe, J. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06187-11 · Cited by 162
Threat to Cefixime Treatment for Gonorrhea
Yokoi, S., Deguchi, T., Ozawa, T., Yasuda, M., Ito, S.-I., Kubota, Y., Tamaki, M., & Maeda, S.-I. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1308.060948 · Cited by 162
Hakenbeck, R., Grebe, T., Zähner, D., & Stock, J. B. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01521.x · Cited by 161
Cited by
Singh, J., Dutta, T., Kim, K.-H., Rawat, M., Samddar, P., & Kumar, P. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0408-4 · Cited by 2,700
Antibiotic resistance: a rundown of a global crisis
Aslam, B., Wang, W., Arshad, M. I., Khurshid, M., Muzammil, S., Rasool, M. H., Nisar, M. A., Alvi, R. F., Aslam, M. A., Qamar, M. U., et al. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s173867 · Cited by 2,552
Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria
Kortright, K. E., Chan, B. K., Koff, J. L., & Turner, P. E. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.01.014 · Cited by 1,212
Li, B., & Webster, T. J. (2018) · Journal of Orthopaedic Research · doi:10.1002/jor.23656 · Cited by 907
Anand, U., Jacobo-Herrera, N., Altemimi, A., & Lakhssassi, N. (2019) · Metabolites · doi:10.3390/metabo9110258 · Cited by 867
Metadata
- Authors
- Fair, R. J., & Tor, Y.
- Venue
- Perspectives in Medicinal Chemistry
- Publisher
- SAGE Publications
- Published
- 2014-01
- Volume
- 6
- Pages
- 25-64
- ISSN
- 1177-391X (ISSN-L)
- OpenAlex
- W2009933778
- Cited by
- 1,955
- References
- 314
- FWCI
- 24.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.